A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 10,773 shares of PFE stock, worth $300,889. This represents 0.12% of its overall portfolio holdings.

Number of Shares
10,773
Previous 10,718 0.51%
Holding current value
$300,889
Previous $308,000 3.25%
% of portfolio
0.12%
Previous 0.14%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $1,423 - $1,635
55 Added 0.51%
10,773 $298,000
Q4 2023

Feb 01, 2024

SELL
$26.13 - $33.94 $27,253 - $35,399
-1,043 Reduced 8.87%
10,718 $308,000
Q3 2023

Oct 13, 2023

SELL
$32.09 - $37.51 $4,492 - $5,251
-140 Reduced 1.18%
11,761 $390,000
Q2 2023

Aug 01, 2023

BUY
$36.12 - $41.79 $1,480 - $1,713
41 Added 0.35%
11,901 $436,000
Q1 2023

May 02, 2023

BUY
$39.39 - $51.28 $8,823 - $11,486
224 Added 1.93%
11,860 $483,000
Q4 2022

Jan 26, 2023

BUY
$41.75 - $54.5 $1,294 - $1,689
31 Added 0.27%
11,636 $0
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $1,444 - $1,762
33 Added 0.29%
11,605 $508,000
Q2 2022

Aug 04, 2022

BUY
$46.53 - $55.17 $9,492 - $11,254
204 Added 1.79%
11,572 $607,000
Q1 2022

Apr 28, 2022

BUY
$45.75 - $56.69 $2,607 - $3,231
57 Added 0.5%
11,368 $589,000
Q4 2021

Jan 24, 2022

BUY
$41.32 - $61.25 $1,942 - $2,878
47 Added 0.42%
11,311 $668,000
Q3 2021

Oct 13, 2021

BUY
$39.25 - $50.42 $2,158 - $2,773
55 Added 0.49%
11,264 $484,000
Q2 2021

Jul 15, 2021

SELL
$35.91 - $40.68 $39,105 - $44,300
-1,089 Reduced 8.86%
11,209 $439,000
Q1 2021

Apr 22, 2021

BUY
$33.49 - $37.77 $37,006 - $41,735
1,105 Added 9.87%
12,298 $446,000
Q4 2020

Mar 03, 2021

BUY
$33.47 - $42.56 $3,146 - $4,000
94 Added 0.85%
11,193 $412,000
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $2,857 - $3,352
90 Added 0.82%
11,099 $407,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $2,831 - $3,434
94 Added 0.86%
11,009 $360,000
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $104,308 - $149,034
-3,859 Reduced 26.12%
10,915 $356,000
Q4 2019

Feb 05, 2020

BUY
$32.92 - $37.36 $2,271 - $2,577
69 Added 0.47%
14,774 $579,000
Q3 2019

Nov 20, 2019

BUY
$32.49 - $42.13 $2,631 - $3,412
81 Added 0.55%
14,705 $528,000
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $3,624 - $4,068
98 Added 0.67%
14,624 $633,000
Q1 2019

May 07, 2019

BUY
$37.5 - $41.2 $3,000 - $3,296
80 Added 0.55%
14,526 $617,000
Q4 2018

Jan 23, 2019

BUY
$38.47 - $43.86 $29,391 - $33,509
764 Added 5.58%
14,446 $631,000
Q3 2018

Nov 15, 2018

BUY
$34.47 - $41.81 $4,170 - $5,059
121 Added 0.89%
13,682 $603,000
Q2 2018

Aug 02, 2018

BUY
$32.98 - $35.16 $1,055 - $1,125
32 Added 0.24%
13,561 $492,000
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $13,051 - $15,141
-409 Reduced 2.93%
13,529 $480,000
Q4 2017

Feb 01, 2018

BUY
$33.26 - $35.29 $15,166 - $16,092
456 Added 3.38%
13,938 $505,000
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $22,568 - $24,861
-728 Reduced 5.12%
13,482 $481,000
Q2 2017

Aug 10, 2017

BUY
N/A
14,210
14,210 $477,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Jackson, Grant Investment Advisers, Inc. Portfolio

Follow Jackson, Grant Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson, Grant Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jackson, Grant Investment Advisers, Inc. with notifications on news.